Suppr超能文献

APC抵抗的实验室诊断:对检测方法的批判性评估及诊断标准的制定

Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria.

作者信息

de Ronde H, Bertina R M

机构信息

Department of Hematology, University Hospital Leiden, The Netherlands.

出版信息

Thromb Haemost. 1994 Dec;72(6):880-6.

PMID:7740458
Abstract

The APC-resistance test consists of two APTT's, one in the presence and one in the absence of a fixed amount of Activated Protein C (APC), and is a simple and reliable method to detect a reduced sensitivity to the anticoagulant action of APC (APC-resistance). At a fixed concentration of APC the prolongation of the APTT is dependent on the activator, the CaCl2 concentration, the citrate concentration in the sample, and on sample handling. The effect of sample handling can be reduced by calculating the APC-Sensitivity Ratio (APC-SR). The actual prolongation of the APTT is also influenced by low protein S levels (reduction of APC-SR) and by reduced levels of factors V, VIII and IX (increase of APC-SR). The APC-SR is most dramatically effected by reduced levels of factors II and X, which result often in "unmeasurable" APC-SR's in plasmas of patients on oral anticoagulant treatment. So at present no reliable APC-SR's can be measured in these patients. Patients treated with heparin can be tested after treatment of their plasma with Hepzym. The inter- and intra-assay variation in the APC-SR is 4% and 2%, respectively, when using the same batches of activator and APC. The variation which is introduced in the APC-SR by use of different batches of activator or APC, or by the use of different APC or CaCl2 concentrations, can effectively be avoided by expressing the result of the test in normalized-APC-SR (n-APC-SR).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

活化部分凝血活酶时间抵抗试验(APC 抵抗试验)包括两次活化部分凝血活酶时间(APTT)检测,一次在加入固定量活化蛋白 C(APC)的情况下进行,另一次在未加 APC 的情况下进行,是检测对 APC 抗凝作用敏感性降低(APC 抵抗)的一种简单可靠的方法。在固定的 APC 浓度下,APTT 的延长取决于激活剂、氯化钙浓度、样本中的枸橼酸盐浓度以及样本处理方式。通过计算 APC 敏感性比值(APC-SR),可减少样本处理的影响。APTT 的实际延长还受低蛋白 S 水平(降低 APC-SR)以及因子 V、VIII 和 IX 水平降低(增加 APC-SR)的影响。因子 II 和 X 水平降低对 APC-SR 的影响最为显著,这常常导致口服抗凝治疗患者血浆中的 APC-SR“无法测量”。因此,目前在这些患者中无法测量可靠的 APC-SR。使用肝素治疗的患者,可在用 Hepzym 处理其血浆后进行检测。当使用同一批次的激活剂和 APC 时,APC-SR 的批间和批内变异分别为 4%和 2%。通过以标准化 APC-SR(n-APC-SR)表示检测结果,可有效避免因使用不同批次的激活剂或 APC,或因使用不同的 APC 或氯化钙浓度而引入的 APC-SR 变异。(摘要截选至 250 字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验